Austar Lifesciences Limited
AULSF
$0.07
$0.071,300.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 152.06% | 128.12% | 114.03% | 56.93% | -2,231.76% |
| Total Depreciation and Amortization | 4.08% | 10.68% | 18.19% | 27.93% | 25.49% |
| Total Amortization of Deferred Charges | 9.46% | 6.03% | 2.59% | 16.08% | 31.76% |
| Total Other Non-Cash Items | -96.64% | -96.32% | -95.98% | -30.26% | 90.92% |
| Change in Net Operating Assets | 119.36% | 119.36% | 119.36% | 69.47% | -21.46% |
| Cash from Operations | 445.20% | 608.62% | 251.79% | 196.83% | 136.46% |
| Capital Expenditure | 34.78% | 57.67% | 70.86% | 54.04% | 36.66% |
| Sale of Property, Plant, and Equipment | -30,429.17% | -9,961.90% | -5,874.40% | -2,404.15% | -87.30% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.32% | 44.81% | 117.58% | 457.76% | 173.50% |
| Cash from Investing | 35.80% | 91.14% | 107.92% | 91.64% | 82.48% |
| Total Debt Issued | -13.51% | -23.30% | -31.47% | -14.39% | -17.81% |
| Total Debt Repaid | -12.77% | -25.93% | -42.61% | -49.44% | -52.27% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.89% | 20.65% | 28.06% | 24.01% | 86.29% |
| Cash from Financing | -1,077.05% | -217.18% | -167.54% | -137.17% | -91.53% |
| Foreign Exchange rate Adjustments | 69.10% | 235.87% | 677.23% | 3.34% | -71.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.53% | -35.68% | -89.34% | 182.37% | 126.69% |